MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women

PHASE2CompletedINTERVENTIONAL
Enrollment

375

Participants

Timeline

Start Date

October 9, 2017

Primary Completion Date

October 19, 2018

Study Completion Date

November 9, 2018

Conditions
Menopause Hot Flashes
Interventions
DRUG

MT-8554 1mg

MT-8554 1mg QD, oral, 12 weeks

DRUG

MT-8554 5mg

MT-8554 5mg QD, oral, 12 weeks

DRUG

MT-8554 10mg

MT-8554 10mg QD, oral, 12 weeks

DRUG

Placebo

Placebo QD, oral, 12 weeks

Trial Locations (63)

19114

Research Site, Philadelphia

21208

Research Site, Baltimore

23502

Research Site, Norfolk

27103

Research Site, Winston-Salem

28557

Research Site, Morehead City

30328

Research Site, Sandy Springs

32081

Research Site, Ponte Vedra

32216

Research Site, Jacksonville

32256

Research Site, Jacksonville

32801

Research Site, Orlando

32806

Research Site, Orlando

33012

Research Site, Hialeah

33016

Research Site, Hialeah

33176

Research Site, New London

Research Site, Miami

33180

Research Site, Aventura

33185

Research Site, Miami

33186

Research Site, Miami

33409

Research Site, West Palm Beach

33414

Research Site, Wellington

33458

Research Site, Jupiter

33759

Research Site, Clearwater

33912

Research Site, Fort Myers

34231

Research Site, Sarasota

34239

Research Site, Sarasota

34429

Research Site, Crystal River

34952

Research Site, Port Saint Lucie

35209

Research Site, Birmingham

36303

Research Site, Dothan

37620

Research Site, Bristol

37920

Research Site, Knoxville

38119

Research Site, Memphis

38305

Research Site, Jackson

43213

Research Site, Columbus

43231

Research Site, Columbus

44122

Research Site, Cleveland

45322

Research Site, Englewood

48504

Research Site, Saginaw

48604

Research Site, Saginaw

49009

Research Site, Kalamazoo

50023

Research Site, Ankeny

59808

Research Site, Missoula

64114

Research Site, Kansas City

67226

Research Site, Wichita

70001

Research Site, Metairie

70072

Research Site, Marrero

76104

Research Site, Fort Worth

78154

Research Site, Schertz

80209

Research Site, Denver

83404

Research Site, Idaho Falls

84020

Research Site, Draper

84107

Research Site, Salt Lake City

84403

Research Site, Ogden

85032

Research Site, Phoenix

89113

Research Site, Las Vegas

89128

Research Site, Las Vegas

90650

Research Site, Norwalk

92111

Research Site, San Diego

95821

Research Site, Sacramento

98042

Research Site, Covington

98105

Research Site, Seattle

06320

Research Site, New London

08648

Research Site, Lawrenceville

All Listed Sponsors
lead

Mitsubishi Tanabe Pharma America Inc.

INDUSTRY